First Choice Medicare

We are pleased to offer Mecoedge 2500, a high-potency injectable formulation of Methylcobalamin (2500 mcg), in our current pharmaceutical inventory. Methylcobalamin is the neurologically active coenzyme form of Vitamin B12, which is essential for the maintenance of the central and peripheral nervous systems. It plays a critical role in the synthesis of myelin, the protective sheath surrounding nerve fibers, and is a vital cofactor in the conversion of homocysteine to methionine, supporting overall cardiovascular and neurological health.

The 2500 mcg concentration provides an intensive therapeutic dose, specifically indicated for the treatment of severe Vitamin B12 deficiency and peripheral neuropathies, such as diabetic neuropathy and sciatica. By delivering the active form of the vitamin directly into the bloodstream via intramuscular or intravenous injection, Mecoedge 2500 bypasses the complexities of gastrointestinal absorption, ensuring rapid and complete bioavailability. This high-strength formulation is particularly effective in promoting nerve regeneration and alleviating symptoms like numbness, tingling, and muscle weakness. To ensure optimal therapeutic outcomes, Mecoedge 2500 should be administered by a healthcare professional according to a prescribed clinical schedule.

We are pleased to offer Saaz, a high-quality formulation of Sulfasalazine (500 mg), in our current pharmaceutical inventory. Sulfasalazine is a potent anti-inflammatory and disease-modifying antirheumatic drug (DMARD) primarily indicated for the management of inflammatory bowel diseases, such as ulcerative colitis and Crohn's disease, as well as the treatment of rheumatoid arthritis. It works through a dual mechanism where its sulfapyridine component acts as an antibacterial agent, while the 5-aminosalicylic acid (5-ASA) component provides a localized anti-inflammatory effect in the colon by inhibiting prostaglandin synthesis. The 500 mg tablet strength is the standard therapeutic dose utilized for both the induction of remission and long-term maintenance therapy, helping to reduce joint swelling, stiffness, and pain while slowing the progression of joint damage. To ensure optimal gastrointestinal tolerance, the tablets should be taken after meals with a full glass of water. Due to its systemic effects and primary metabolism in the liver and kidneys, Saaz 500 mg must be used strictly under the supervision of a healthcare professional, with regular monitoring of complete blood counts (CBC) and hepatic function to ensure the highest level of patient safety and clinical efficacy.